Pulse Biosciences, Inc. Increase (Decrease) in Accounts Receivable
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Accounts Receivable of -$98.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$43.00K.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$55.00K.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $259.00K.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $15.00K.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $274.00K.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
- Pulse Biosciences, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$61.00K, a 200.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$98.00K 10-Q · filed 2026-08-06 | $161.00K derived: sum of 3 quarters · filed 2026-08-06 | $176.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$55.00K 10-Q · filed 2026-05-14 | $204.00K derived: sum of 2 quarters · filed 2026-05-14 | $219.00K derived: sum of 3 quarters · filed 2026-05-14 | $219.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $274.00K derived: sum of 2 quarters · filed 2026-02-19 | $274.00K derived: sum of 3 quarters · filed 2026-08-06 | $274.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $15.00K derived: sum of 2 quarters · filed 2026-08-06 | $15.00K 10-Q · filed 2025-11-05 | $15.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 derived: sum of 3 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | -$5.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | -$5.00K derived: sum of 3 quarters · filed 2024-03-28 | -$8.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | -$5.00K derived: sum of 2 quarters · filed 2024-03-28 | -$8.00K derived: sum of 3 quarters · filed 2024-03-28 | -$21.00K derived: sum of 4 quarters · filed 2024-03-28 |
| 2022-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$8.00K derived: sum of 2 quarters · filed 2024-03-28 | -$21.00K derived: sum of 3 quarters · filed 2024-03-28 | -$61.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$16.00K derived: sum of 2 quarters · filed 2023-11-13 | -$56.00K 10-Q · filed 2023-11-13 | -$67.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$53.00K 10-Q · filed 2023-08-10 | -$64.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$40.00K 10-Q · filed 2023-05-11 | -$51.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $61.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $72.00K 10-Q · filed 2022-11-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |